The prevalence of lower extremity venous disease in our population is greater than that of peripheral arterial occlusive disease, although the latter receives more attention. An estimated 35 percent of the adult population has lower extremity venous abnormalities and one-fifth of these individuals will acquire one or more venous ulcers in their lifetime.
Wound Science InitiativeThe Healogics Wound Science Initiative recognizes the value and relevance of data to drive continuous, collaborative learning towards a better understanding of how to efficiently utilize healthcare resources to effectively manage this growing population. Review data and insights from our research.
To advance insights and perspectives on how to better manage the care of patients with chronic wounds and to stimulate potential solutions for improving outcomes and reducing costs for this vulnerable, majority 65+ population, Healogics analyzed 2014 Centers for Medicare & Medicaid Services (CMS) Part A and B standard analytic files for care utilization and cost trends. This white paper synthesizes information and insights gleaned from the analysis, keeping in mind potential areas of opportunity to improve care and outcomes.
Healogics researchers partnered with Dr. Alexandra Nowakowski, a leading patient advocate and medical researcher at Florida State University’s College of Medicine, to investigate physician perceptions of wound care. Healogics physicians were recruited to participate in an anonymous nine-question survey focused on their experiences and perceptions of wound care and wounded patients. The questions focused on patient attributes that influence positive or negative wound outcomes, patient impacts on physicians’ care plan and physicians’ perspective of patient-centered wound care.
Foot ulcerations are one of the most common complications affecting patients with diabetes mellitus. One in four diabetic individuals will develop a lower extremity ulceration, most commonly in the mid to later stages of life. The Wound Care Center® has a thorough approach to evaluating and managing these difficult diabetic foot wounds. Healing is achieved in cooperation with referring physicians, surgeons, podiatrists and patients.
Impact of Hyperbaric Oxygen on More Advanced Wagner Grades 3 and 4 Diabetic Foot Ulcers: Matching Therapy to Specific Wound Conditions
The goal of this research was to identify a population of diabetic foot ulcer patients who demonstrate a significant response to hyperbaric oxygen therapy (HBOT) using a large sample size to provide guidance for clinicians when treating these complicated patients.
Monograph: The Clinical Case for Use of Hyperbaric Oxygen Therapy in the Treatment of Diabetic Wounds
Although diabetes can ravage the body in many ways, non-healing ulcers on the feet and lower legs are common outward manifestations of the disease. Also, diabetics often suffer from nerve damage in their feet and legs, allowing small wounds or irritations to develop unnoticed. Given the abnormalities of the microvasculature and other side effects of diabetes, these wounds take a long time to heal and require a specialized treatment approach for proper healing.
The purpose of this analysis is to identify trends in hyperbaric oxygen therapy (HBOT) patient treatment consistency and wound outcomes with a focus on the diabetic wound of the lower extremity (DWLE) patient.